Rebel Medicine Overview
Rebel Medicine is a pre-clinical specialty pharmaceutical company developing non-opioid solutions for acute pain management. Our flagship product is an injectable long-acting local anesthetic that can provide 72 hours of non-opioid postoperative pain management. It can be used in nearly any surgical procedure, either locally at the surgical site or injected as a nerve block agent. We’re currently performing IND-enabling studies and preparing for our clinical program. We’ve raised a total of $3M seed round and have received $1.8M in non-dilutive grant funding from the NSF, NIH, and the State of Utah. We are currently seeking partners and investors for our clinical program beginning in 2024.
Contact us for our pitch deck!
Address: 630 Komas Dr Suite 300, Salt Lake City, UT 84108